Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Amifostine may be effective in reducing pain, numbness, tingling, and other
symptoms of peripheral neuropathy.
PURPOSE: This phase II trial is studying how well amifostine works in reducing pain,
numbness, tingling, and other symptoms of peripheral neuropathy in patients who have received
paclitaxel for solid tumors.